174 related articles for article (PubMed ID: 14986247)
1. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem.
Gerding DN
Clin Infect Dis; 2004 Mar; 38(5):646-8. PubMed ID: 14986247
[No Abstract] [Full Text] [Related]
2. High levels of resistance to fluoroquinolones among Clostridium difficile isolates in a Spanish hospital.
Sánchez-Somolinos M; Alcalá L; Peláez T; Marín M; Martín A; Catalán P; Bouza E
Clin Infect Dis; 2008 Sep; 47(6):818-22. PubMed ID: 18680418
[No Abstract] [Full Text] [Related]
3. [Detection of ermB gene responsible for high level resistance to clindamycin (MLS type resistance) among Clostridium difficile strains isolated from antibiotic associated diarrhea (AAD)].
Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2003; 55(1):61-6. PubMed ID: 12908416
[TBL] [Abstract][Full Text] [Related]
4. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.
Gaynes R; Rimland D; Killum E; Lowery HK; Johnson TM; Killgore G; Tenover FC
Clin Infect Dis; 2004 Mar; 38(5):640-5. PubMed ID: 14986246
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile-associated diarrhoea.
Elliott B; Chang BJ; Golledge CL; Riley TV
Intern Med J; 2007 Aug; 37(8):561-8. PubMed ID: 17640189
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance.
Razavi B; Apisarnthanarak A; Mundy LM
Infection; 2007 Oct; 35(5):300-7. PubMed ID: 17885732
[TBL] [Abstract][Full Text] [Related]
7. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.
Loo VG; Poirier L; Miller MA; Oughton M; Libman MD; Michaud S; Bourgault AM; Nguyen T; Frenette C; Kelly M; Vibien A; Brassard P; Fenn S; Dewar K; Hudson TJ; Horn R; René P; Monczak Y; Dascal A
N Engl J Med; 2005 Dec; 353(23):2442-9. PubMed ID: 16322602
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital.
Martirosian G; Szczesny A; Cohen SH; Silva J
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):153-5. PubMed ID: 15964504
[TBL] [Abstract][Full Text] [Related]
9. Resistance determinants in strains of Clostridium difficile from two geographically distinct populations.
Bendle JS; James PA; Bennett PM; Avison MB; Macgowan AP; Al-Shafi KM
Int J Antimicrob Agents; 2004 Dec; 24(6):619-21. PubMed ID: 15555889
[TBL] [Abstract][Full Text] [Related]
10. Poor infection control, not fluoroquinolones, likely to be primary cause of Clostridium difficile-associated diarrhea outbreaks in Quebec.
Weiss K
Clin Infect Dis; 2006 Mar; 42(5):725-7; author reply 727-9. PubMed ID: 16447121
[No Abstract] [Full Text] [Related]
11. Antimicrobial resistance of Clostridium difficile isolates in a tertiary medical center, Israel.
Bishara J; Bloch Y; Garty M; Behor J; Samra Z
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):141-4. PubMed ID: 16406180
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile.
Schmidt C; Löffler B; Ackermann G
Diagn Microbiol Infect Dis; 2007 Sep; 59(1):1-5. PubMed ID: 17509804
[TBL] [Abstract][Full Text] [Related]
13. Epidemic Clostridium difficile.
Wilcox MH; Freeman J
N Engl J Med; 2006 Mar; 354(11):1199-203; author reply 1199-203. PubMed ID: 16544390
[No Abstract] [Full Text] [Related]
14. [Survey of susceptibility of clinical Clostridium diffiicile strains isolated from patients hospitalised in different departments of paediatric hospital to antimicrobial agents].
Wultańska D; Obuch-Woszczatyński P; Pituch H; Luczak M
Med Dosw Mikrobiol; 2007; 59(2):161-8. PubMed ID: 17929413
[TBL] [Abstract][Full Text] [Related]
15. Diversity of multidrug-resistant epidemic Clostridium difficile NAP1/RT027/ST01 strains in tertiary hospitals from Honduras.
Hidalgo-Villeda F; Tzoc E; Torres L; Bu E; Rodríguez C; Quesada-Gómez C
Anaerobe; 2018 Aug; 52():75-78. PubMed ID: 29890209
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates.
Zheng L; Citron DM; Genheimer CW; Sigmon SF; Carman RJ; Lyerly DM; Goldstein EJ
Anaerobe; 2007; 13(3-4):114-20. PubMed ID: 17531516
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of the ermB gene in Clostridium difficile strains isolated at a university teaching hospital from 1987 through 1998.
Tang-Feldman YJ; Henderson JP; Ackermann G; Feldman SS; Bedley M; Silva J; Cohen SH
Clin Infect Dis; 2005 May; 40(10):1537-40. PubMed ID: 15844079
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile-associated diarrhea: resurgence with a vengeance.
Oldfield EC
Rev Gastroenterol Disord; 2006; 6(2):79-96. PubMed ID: 16699477
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone use and Clostridium difficile-associated diarrhea.
McCusker ME; Harris AD; Perencevich E; Roghmann MC
Emerg Infect Dis; 2003 Jun; 9(6):730-3. PubMed ID: 12781017
[TBL] [Abstract][Full Text] [Related]
20. Probiotics for Clostridium difficile diarrhea: putting it into perspective.
Karpa KD
Ann Pharmacother; 2007 Jul; 41(7):1284-7. PubMed ID: 17595302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
